Award to support the development of molecules to inhibit BamA protein Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of US$610k to Justus Liebig ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

After Novo Nordisk (NVO) reported results from its Phase 3b STEP UP trial, which showed that adults with obesity achieved a 20.7% weight loss ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

A new error grid to assess the accuracy of glucose measurements could give continuous glucose monitor manufacturers and ...

Europe Pharmaceutical Drugs Market Projected To Witness Substantial Growth, 2025-2032: Astrazeneca., Baxter, Novartis AG Europe pharmaceutical drugs market is estimated to be valued at US$ 180.2 Bn in ...